Retagliptin phosphate 是一种选择性、竞争性、口服活性的二肽基肽酶 4 (DPP-4) 抑制剂。Retagliptin phosphate 能够用于 2 型糖尿病 (T2DM) 的研究。

Retagliptin Phosphate is pharmaceutical composition of DPP-4 inhibitor, for treating type-2 diabetes.

1256756-88-3

C19H21F6N4O7P

562.36

SP 2086;瑞格列汀磷酸盐

DMSO:≥ 150 mg/mL (266.73 mM)
Powder: -20°C for 3 years
In solvent: -80°C for 2 years